COPD 患者的疫苗接种：新冠疫情提高了标准。
Vaccination in patients with COPD: COVID has raised the bar.
机构信息
School of Medicine, University of Western Australia, Royal Perth Hospital, Perth, Western Australia, Australia.
出版信息
Respirology. 2022 Oct;27(10):799-800. doi: 10.1111/resp.14331. Epub 2022 Jul 18.
Abstract
See related article
摘要
查看相关文章
相似文献
1
Vaccination in patients with COPD: COVID has raised the bar.COPD 患者的疫苗接种：新冠疫情提高了标准。
Respirology. 2022 Oct;27(10):799-800. doi: 10.1111/resp.14331. Epub 2022 Jul 18.
2
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.流感和肺炎球菌疫苗对慢性阻塞性肺疾病加重的影响。
Respirology. 2022 Oct;27(10):844-853. doi: 10.1111/resp.14309. Epub 2022 Jun 15.
3
The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing.北京市 COPD 患者疫苗接种现状及 COVID-19 对其接种意愿的影响。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 8;16:3337-3346. doi: 10.2147/COPD.S340730. eCollection 2021.
4
Should Patients With COPD Be Vaccinated?慢性阻塞性肺疾病患者应该接种疫苗吗？
Respir Care. 2015 Feb;60(2):239-43. doi: 10.4187/respcare.03350. Epub 2014 Oct 14.
5
Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.流感疫苗而非肺炎球菌疫苗可预防慢性阻塞性肺疾病（COPD）患者的全因死亡率。
Thorax. 2009 Jul;64(7):567-72. doi: 10.1136/thx.2008.106286. Epub 2009 Mar 24.
6
[Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].[流感疫苗和23价肺炎球菌多糖疫苗对慢性阻塞性肺疾病老年人的影响：一项基于社区的干预研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Jun 10;39(6):792-798. doi: 10.3760/cma.j.issn.0254-6450.2018.06.019.
7
[Focus on influenza vaccination in patients with chronic obstructive pulmonary disease].关注慢性阻塞性肺疾病患者的流感疫苗接种
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Apr 12;45(4):333-334. doi: 10.3760/cma.j.cn112147-20220124-00068.
8
[Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].[肺炎球菌疫苗和流感疫苗预防慢性阻塞性肺疾病患者病情加重]
Nihon Rinsho. 2016 May;74(5):839-42.
9
Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.西班牙加泰罗尼亚地区慢性阻塞性肺疾病患者向医生咨询时流感和肺炎球菌疫苗接种的依从性
J Infect. 2007 Jan;54(1):65-74. doi: 10.1016/j.jinf.2005.11.020. Epub 2006 Oct 16.
10
Barriers and facilitators to vaccination uptake against COVID-19, influenza, and pneumococcal pneumonia in immunosuppressed adults with immune-mediated inflammatory diseases: A qualitative interview study during the COVID-19 pandemic.COVID-19、流感和肺炎球菌性肺炎疫苗接种在免疫抑制的免疫介导性炎症疾病成人中的接受障碍和促进因素：COVID-19 大流行期间的定性访谈研究。
PLoS One. 2022 Sep 9;17(9):e0267769. doi: 10.1371/journal.pone.0267769. eCollection 2022.
引用本文的文献
1
The Saudi thoracic society guidelines for vaccinations in adult patients with chronic respiratory diseases.沙特胸科学会关于慢性呼吸道疾病成年患者疫苗接种的指南。
Ann Thorac Med. 2025 Jan-Mar;20(1):36-48. doi: 10.4103/atm.atm_202_24. Epub 2024 Oct 16.
本文引用的文献
1
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbations.流感和肺炎球菌疫苗对慢性阻塞性肺疾病加重的影响。
Respirology. 2022 Oct;27(10):844-853. doi: 10.1111/resp.14309. Epub 2022 Jun 15.
2
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.美国成人中 15 价肺炎球菌结合疫苗和 20 价肺炎球菌结合疫苗的使用：免疫实践咨询委员会更新的建议-美国，2022 年。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):109-117. doi: 10.15585/mmwr.mm7104a1.
3
Comparative effectiveness of pneumococcal vaccination with PPV23 and PCV13 in COPD patients over a 5-year follow-up cohort study.在一项为期 5 年的随访队列研究中，比较肺炎球菌疫苗（PPV23）和肺炎球菌结合疫苗（PCV13）在 COPD 患者中的有效性。
Sci Rep. 2021 Aug 5;11(1):15948. doi: 10.1038/s41598-021-95129-w.
4
Prevalence of influenza and pneumococcal vaccination in chronic obstructive pulmonary disease patients in association with the occurrence of acute exacerbations.慢性阻塞性肺疾病患者中流感和肺炎球菌疫苗接种率与急性加重发生情况的相关性
J Thorac Dis. 2020 Aug;12(8):4233-4242. doi: 10.21037/jtd-20-814.
5
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study.早期、低剂量、短期使用皮质类固醇对非重症COVID-19肺炎成年住院患者的疗效评估：一项回顾性队列研究
Infect Dis Ther. 2020 Dec;9(4):823-836. doi: 10.1007/s40121-020-00332-3. Epub 2020 Sep 2.
6
Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.流感疫苗对预防老年慢性阻塞性肺疾病患者住院的效果。
J Infect Dis. 2020 Jan 1;221(1):42-52. doi: 10.1093/infdis/jiz419.
7
Seasonal influenza vaccination in patients with COPD: a systematic literature review.慢性阻塞性肺疾病患者的季节性流感疫苗接种：一项系统文献综述
BMC Pulm Med. 2017 May 3;17(1):79. doi: 10.1186/s12890-017-0420-8.
8
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.用于预防慢性阻塞性肺疾病患者肺炎的肺炎球菌疫苗。
Cochrane Database Syst Rev. 2017 Jan 24;1(1):CD001390. doi: 10.1002/14651858.CD001390.pub4.
9
Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.多糖结合疫苗预防成人肺炎球菌性肺炎。
N Engl J Med. 2015 Mar 19;372(12):1114-25. doi: 10.1056/NEJMoa1408544.
10
Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network.2013年澳大利亚哨点医院的流感流行病学、疫苗接种率及疫苗效力：流感并发症预警网络
Commun Dis Intell Q Rep. 2014 Jun 30;38(2):E143-9.
Zotero 插件